 |
| Roxanne Taylor |
Roxanne Taylor, former Accenture chief marketing and communications officer will join Memorial Sloan Kettering Cancer Center on Feb. 3 as its chief marketing and communications officer.
At MSK, Taylor will be responsible for shaping and enhancing the brand and will have accountability for building its long-term equity with all stakeholders. She will lead an integrated marketing and communications function focused on helping to grow and differentiate MSK’s brand presence worldwide.
Since leaving Accenture in September 2018 after 23 years, Taylor has served on the board of directors at Whalar, which provides tech-driven influencer marketing solutions, as well as at Pure Storage, a provider of all-flash data hardware and software solutions; and OpenX, the world’s largest independent advertising exchange.
She is also on the boards of the Association of Executive Search and Leadership Consultants, and the US chapter of press freedom organization Reporters Sans Frontières.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
